Background illustration for clinical trials search

Paid Clinical Trials Madison

Discover 514 paid clinical trials in Madison, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 514

A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

for

Primary Membranous Nephropathy

Location: Madison WI, Detroit MI, Cleveland OH, London,

Sponsor: Biogen

Sex: All

Age: 18 - 70+

Code: NCT06962800

Phase3, Recruiting

Worldwide Yearly Screening for Hypospadias

for

Hypospadias

Location: Madison WI

Sponsor: University of Wisconsin, Madison

Sex: Male

Age: 5 - 65

Code: NCT06966375

Recruiting

Differences in Postoperative Symptoms With Four Ureteral Stents

for

Urinary Stone

Location: Madison WI

Sponsor: University of Wisconsin, Madison

Sex: All

Age: 18 - 70+

Code: NCT06083051

Recruiting

Femoral BMD Change Following Cemented or Cementless Total Knee Arthroplasty

for

Knee Arthropathy

Location: Madison WI

Sponsor: University of Wisconsin, Madison

Sex: All

Age: 55+

Code: NCT06733597

Recruiting

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

for

NonSegmental Vitiligo

Location: Madison WI, Milwaukee WI, Skokie IL, Chicago IL,

Sponsor: Incyte Corporation

Sex: All

Age: 2 - 11

Code: NCT06548360

Phase3, Recruiting

Bucillamine Phase 2 Trial in Patients With Cystinuria

for

Cystinuria

Location: Madison WI, Birmingham AL, New York NY, Warwick RI,

Sponsor: Revive Therapeutics, Ltd.

Sex: All

Age: 18 - 70+

Code: NCT02942420

Phase2, Recruiting

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

for

Myelodysplastic Syndrome

Location: Madison WI, Milwaukee WI, DeKalb IL, Dixon IL,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06577441

Phase2, Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for

Colorectal Neoplasms

Location: Madison WI, Arlington Heights IL, Iowa City IA,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06662786

Phase3, Recruiting

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

for

Carcinoma, Hepatocellular, Cirrhosis

Location: Madison WI, Ann Arbor MI, St Louis MO, Omaha NE,

Sponsor: VA Office of Research and Development

Sex: All

Age: 18 - 70+

Code: NCT05486572

Recruiting

Trauma-Informed Guilt Reduction Therapy Compared to Prolonged Exposure

for

Stress Disorders, Post-Traumatic

Location: Madison WI, Little Rock AR, New Orleans LA,

Sponsor: Veterans Medical Research Foundation

Sex: All

Age: 18+

Code: NCT06296589

Recruiting

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

for

Prostate Cancer, Oligometastasis, Oligorecurrence,

Location: Madison WI, Milwaukee WI, Hines IL, Indianapolis IN,

Sponsor: VA Office of Research and Development

Sex: Male

Age: 18+

Code: NCT04787744

Phase2, Phase3, Recruiting

Tailor VHA HH Bundle for Acute Mental Health Care

for

Hand Hygiene Compliance

Location: Madison WI, Hines IL, Iowa City IA, Minneapolis MN

Sponsor: VA Office of Research and Development

Sex: All

Age: 18 - 70+

Code: NCT07607145

Recruiting

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

for

Acute Myeloid Leukemia

Location: Madison WI, Milwaukee WI, DeKalb IL, Grayslake IL,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06672146

Phase2, Recruiting

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

for

Castration-Sensitive Prostate Carcinoma,

Location: Madison WI, Brookfield WI, West Bend WI,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: Male

Age: 18+

Code: NCT06931340

Phase3, Recruiting

CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)

for

Heart Failure

Location: Madison WI, Minneapolis MN, Ann Arbor MI, Birmingham AL,

Sponsor: VA Office of Research and Development

Sex: All

Age: 60+

Code: NCT05996328

Recruiting

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

for

Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia

Location: Madison WI, Oconomowoc WI, Mukwonago WI, Waukesha WI,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 65+

Code: NCT07321652

Phase3, Recruiting

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

for

Metastatic Prostate Cancer

Location: Madison WI, St Louis MO, Louisville KY, Kansas City MO,

Sponsor: VA Office of Research and Development

Sex: Male

Age: 18+

Code: NCT05011383

Phase2, Recruiting

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

for

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,

Location: Madison WI, Summit WI, Burlington WI, Brookfield WI,

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT04566328

Phase3, Recruiting

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

for

Biochemically Recurrent Prostate Carcinoma,

Location: Madison WI, Johnson Creek WI, Rockford IL, DeKalb IL,

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: Male

Age: 18+

Code: NCT04423211

Phase3, Recruiting

Resistant Potato Starch to Alleviate GWI

for

Gulf War Illness

Location: Madison WI

Sponsor: VA Office of Research and Development

Sex: All

Age: 50 - 70+

Code: NCT05820893

Phase2, Recruiting

Paid Clinical Trials Madison

Filter results

A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

Worldwide Yearly Screening for Hypospadias

Differences in Postoperative Symptoms With Four Ureteral Stents

Femoral BMD Change Following Cemented or Cementless Total Knee Arthroplasty

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

Interested in new trials?

Bucillamine Phase 2 Trial in Patients With Cystinuria

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Trauma-Informed Guilt Reduction Therapy Compared to Prolonged Exposure

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

Tailor VHA HH Bundle for Acute Mental Health Care

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Resistant Potato Starch to Alleviate GWI